Hutchison China MediTech Ltd ADR Stock
A loss of -2.600% shows a downward development for Hutchison China MediTech Ltd ADR.
Our community is currently high on Hutchison China MediTech Ltd ADR with 5 Buy predictions and 1 Sell predictions.
With a target price of 16 € there is a hugely positive potential of 71.12% for Hutchison China MediTech Ltd ADR compared to the current price of 9.35 €.
Pros and Cons of Hutchison China MediTech Ltd ADR in the next few years
Pros
?
B****
?
M***** P*******
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Hutchison China MediTech Ltd ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Hutchison China MediTech Ltd ADR | -2.600% | 0.524% | 6.667% | -39.623% | -11.927% | -24.409% | -71.765% |
| China Traditional Chinese Medicine Co Ltd | - | 0.000% | 0.000% | -9.836% | 0.917% | -46.602% | -56.000% |
| China Resources Pharmaceutical Group Ltd | 0.000% | 2.885% | 11.925% | -10.084% | 12.395% | -24.648% | 22.146% |
| Repligen Corp. | 0.120% | 0.652% | 3.044% | 13.819% | -12.283% | -21.804% | -39.078% |
Comments
HUTCHMED (HCM) had its price target lowered by Bank of America Corporation from $20.00 to $17.00. They now have a "buy" rating on the stock.
Show more
Ratings data for HCM provided by MarketBeat
HUTCHMED (HCM) had its price target lowered by Bank of America Corporation from $21.00 to $20.00. They now have a "buy" rating on the stock.
Show more
Ratings data for HCM provided by MarketBeat
HUTCHMED (NASDAQ:HCM) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Show more
Ratings data for HCM provided by MarketBeat